메뉴 건너뛰기




Volumn 107, Issue 6, 2000, Pages 1171-1177

Effects of systemic β-blocker therapy on the efficacy and safety of topical brimonidine and timolol

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; METOPROLOL; NADOLOL; PROPRANOLOL; TIMOLOL;

EID: 0033768959     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(00)00081-6     Document Type: Article
Times cited : (80)

References (11)
  • 2
    • 0032901575 scopus 로고    scopus 로고
    • Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-Year results in glaucoma patients. Brimonidine Study Group
    • (1999) Am J Ophthalmol , vol.127 , pp. 20-26
    • Katz, L.J.1
  • 4
    • 0029731764 scopus 로고    scopus 로고
    • Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension
    • (1996) Surv Ophthalmol , vol.41 , Issue.SUPPL. 1
    • Schuman, J.S.1
  • 5
    • 0030877607 scopus 로고    scopus 로고
    • A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter trial. Chronic Brimonidine Study Group
    • Comment in: Arch Ophthalmol 1999;117:417-9
    • (1997) Arch Ophthalmol , vol.115 , pp. 847-852
    • Schuman, J.S.1    Horwitz, B.2    Choplin, N.T.3
  • 6
    • 0031793877 scopus 로고    scopus 로고
    • Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension
    • (1998) Ophthalmology , vol.105 , pp. 1960-1967
    • Le Blanc, R.P.1
  • 8
    • 0007545193 scopus 로고
    • Reduced ocular hypotensive effect of topical β-blockers in glaucoma patients receiving oral β-blockers
    • (1992) J Glaucoma , vol.1 , pp. 174-177
    • Gross, F.J.1    Schuman, J.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.